Ultragenyx Pharmaceutical Inc. - RARE
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| May 18, 2026 | — | A | A | 14,058.0 | 0.0 | 0.0 | 14,058.0 | View | |
| May 18, 2026 | — | A | A | 7,751.0 | 0.0 | 0.0 | 33,696.0 | View | |
| May 18, 2026 | — | A | A | 14,058.0 | 0.0 | 0.0 | 14,058.0 | View | |
| May 18, 2026 | — | A | A | 7,751.0 | 0.0 | 0.0 | 31,116.0 | View | |
| May 18, 2026 | — | A | A | 14,058.0 | 0.0 | 0.0 | 14,058.0 | View | |
| May 18, 2026 | — | A | A | 7,751.0 | 0.0 | 0.0 | 23,095.0 | View | |
| May 18, 2026 | — | A | A | 14,058.0 | 0.0 | 0.0 | 14,058.0 | View | |
| May 18, 2026 | — | S | D | 5,740.0 | 25.12 | 144,188.8 | 27,951.0 | View | |
| May 18, 2026 | — | A | A | 7,751.0 | 0.0 | 0.0 | 33,691.0 | View | |
| May 18, 2026 | — | A | A | 14,058.0 | 0.0 | 0.0 | 14,058.0 | View | |
| May 18, 2026 | — | A | A | 7,751.0 | 0.0 | 0.0 | 40,441.0 | View | |
| May 18, 2026 | — | A | A | 14,058.0 | 0.0 | 0.0 | 14,058.0 | View | |
| May 18, 2026 | — | A | A | 7,751.0 | 0.0 | 0.0 | 40,441.0 | View | |
| May 18, 2026 | — | A | A | 14,058.0 | 0.0 | 0.0 | 14,058.0 | View | |
| May 18, 2026 | — | A | A | 7,751.0 | 0.0 | 0.0 | 38,566.0 | View | |
| May 06, 2026 | EVP and Chief Medical Officer | S | D | 344.0 | 24.96 | 8,586.24 | 111,189.0 | View | |
| May 04, 2026 | Chief Financial Officer | S | D | 4,683.0 | 24.9 | 116,606.7 | 110,342.0 | View | |
| Apr 24, 2026 | SVP, Chief Accounting Officer | A | A | 7,348.0 | 0.0 | 0.0 | 7,348.0 | View | |
| Apr 24, 2026 | SVP, Chief Accounting Officer | A | A | 20,241.0 | 0.0 | 0.0 | 68,911.0 | View | |
| Apr 20, 2026 | President & CEO | A | A | 132,693.0 | 0.0 | 0.0 | 132,693.0 | View | |
| Apr 20, 2026 | President & CEO | A | A | 76,745.0 | 0.0 | 0.0 | 735,739.0 | View | |
| Apr 20, 2026 | See Remarks | A | A | 79,936.0 | 0.0 | 0.0 | 79,936.0 | View | |
| Apr 20, 2026 | See Remarks | A | A | 23,116.0 | 0.0 | 0.0 | 147,845.0 | View | |
| Apr 20, 2026 | See Remarks | A | A | 79,936.0 | 0.0 | 0.0 | 79,936.0 | View | |
| Apr 20, 2026 | See Remarks | A | A | 23,116.0 | 0.0 | 0.0 | 133,142.0 | View | |
| Apr 20, 2026 | EVP and Chief Legal Officer | A | A | 49,960.0 | 0.0 | 0.0 | 49,960.0 | View | |
| Apr 20, 2026 | EVP and Chief Legal Officer | A | A | 28,895.0 | 0.0 | 0.0 | 95,715.0 | View | |
| Apr 20, 2026 | EVP & Chief Commercial Officer | A | A | 49,960.0 | 0.0 | 0.0 | 49,960.0 | View | |
| Apr 20, 2026 | EVP & Chief Commercial Officer | A | A | 28,895.0 | 0.0 | 0.0 | 118,410.0 | View | |
| Apr 20, 2026 | EVP and Chief Medical Officer | A | A | 59,952.0 | 0.0 | 0.0 | 59,952.0 | View | |
| Apr 20, 2026 | EVP and Chief Medical Officer | A | A | 34,674.0 | 0.0 | 0.0 | 110,975.0 | View | |
| Apr 20, 2026 | Chief Financial Officer | A | A | 59,952.0 | 0.0 | 0.0 | 59,952.0 | View | |
| Apr 20, 2026 | Chief Financial Officer | A | A | 34,674.0 | 0.0 | 0.0 | 115,025.0 | View | |
| Apr 02, 2026 | Chief Financial Officer | S | D | 4,683.0 | 20.97 | 98,202.51 | 80,351.0 | View | |
| Mar 10, 2026 | EVP and Chief Legal Officer | S | D | 3,508.0 | 22.67 | 79,526.36 | 66,820.0 | View | |
| Mar 10, 2026 | EVP and Chief Legal Officer | S | D | 6,018.0 | 21.4 | 128,785.2 | 70,328.0 | View | |
| Mar 03, 2026 | EVP and Chief Medical Officer | S | D | 7,029.0 | 22.8 | 160,261.2 | 76,301.0 | View | |
| Mar 03, 2026 | EVP and Chief Medical Officer | A | A | 11,643.0 | 0.0 | 0.0 | 83,173.0 | View | |
| Mar 03, 2026 | Chief Financial Officer | S | D | 1,635.0 | 22.4 | 36,624.0 | 85,034.0 | View | |
| Mar 03, 2026 | Chief Financial Officer | S | D | 3,119.0 | 22.54 | 70,302.26 | 86,669.0 | View | |
| Mar 03, 2026 | Chief Financial Officer | S | D | 5,290.0 | 22.8 | 120,612.0 | 89,788.0 | View | |
| Mar 03, 2026 | Chief Financial Officer | A | A | 6,143.0 | 0.0 | 0.0 | 95,078.0 | View | |
| Mar 03, 2026 | SVP, Chief Accounting Officer | S | D | 1,632.0 | 22.8 | 37,209.6 | 48,670.0 | View | |
| Mar 03, 2026 | SVP, Chief Accounting Officer | F | D | 148.0 | 23.39 | 3,461.72 | 50,302.0 | View | |
| Mar 03, 2026 | EVP and Chief Legal Officer | S | D | 8,135.0 | 22.8 | 185,478.0 | 76,346.0 | View | |
| Mar 03, 2026 | EVP and Chief Legal Officer | A | A | 11,137.0 | 0.0 | 0.0 | 84,408.0 | View | |
| Mar 03, 2026 | President & CEO | S | D | 54,404.0 | 22.8 | 1,240,411.2 | 658,994.0 | View | |
| Mar 03, 2026 | President & CEO | A | A | 71,177.0 | 0.0 | 0.0 | 712,908.0 | View | |
| Mar 03, 2026 | EVP & Chief Commercial Officer | S | D | 10,539.0 | 22.8 | 240,289.2 | 89,515.0 | View | |
| Mar 03, 2026 | EVP & Chief Commercial Officer | A | A | 11,643.0 | 0.0 | 0.0 | 99,498.0 | View | |
| Mar 03, 2026 | See Remarks | S | D | 10,029.0 | 22.8 | 228,661.2 | 110,026.0 | View | |
| Mar 03, 2026 | See Remarks | A | A | 11,137.0 | 0.0 | 0.0 | 119,565.0 | View | |
| Mar 03, 2026 | See Remarks | F | D | 999.0 | 23.39 | 23,366.61 | 124,729.0 | View | |
| Mar 03, 2026 | See Remarks | A | A | 11,137.0 | 0.0 | 0.0 | 125,728.0 | View | |
| Feb 03, 2026 | Chief Financial Officer | S | D | 3,061.0 | 23.56 | 72,117.16 | 88,935.0 | View | |
| Jan 05, 2026 | Chief Financial Officer | S | D | 3,150.0 | 22.84 | 71,946.0 | 91,996.0 | View | |
| Dec 30, 2025 | SVP, Chief Accounting Officer | S | D | 85.0 | 34.38 | 2,922.3 | 50,450.0 | View | |
| Dec 11, 2025 | Chief Financial Officer | S | D | 3,081.0 | 36.38 | 112,086.78 | 95,146.0 | View |